Navigation Links
Misonix Reports Strong Revenue Increases for the Three Months and Full-Year Ended June 30, 2012
Date:9/18/2012

FARMINGDALE, N.Y., Sept. 18, 2012 /PRNewswire/ -- Misonix, Inc. (NASDAQ: MSON), a surgical device company that designs, manufactures and markets innovative therapeutic ultrasonic products worldwide for spine surgery, cranial maxillo – facial surgery, neurosurgery,  wound debridement, cosmetic surgery, laparoscopic surgery and other surgical applications, today reported financial results for the fourth quarter and the fiscal year ending June 30, 2012.

Highlights for the quarter and the fiscal year include:

  • Sales for the fourth quarter of fiscal 2012 increased 41% to $5.3 million compared to $3.8 million in the comparable quarter of fiscal 2011. For the fiscal year, revenues increased 27% to $15.7 million compared to $12.4 million for the full year ending June 30, 2011.
  • Gross margin increased 100 basis points to 58% for the three months ended June 30, 2012 versus June 30, 2011. For the fiscal year, gross margin increased 150 basis points to 59%.
  • BoneScalpel™ revenues increased 82% for the fourth quarter versus the prior year three month period. For the fiscal year, BoneScalpel revenues increased 92% versus the comparable period last year.
  • SonicOne™ revenues increased 89% for the fourth quarter versus the comparable quarter of fiscal 2011. SonicOne revenues increased 17% for the fiscal year versus the comparable period last year.
  • SonaStar™ revenues increased 21% for the fourth quarter versus the comparable quarter of fiscal 2011. SonaStar revenues increased 44% for the fiscal year versus the comparable period last year.
  • Net income for the quarter was $444,813, or $0.06 per diluted share, compared to a net loss of $1.45 million, or $(0.21) per diluted share in the fourth quarter of 2011. For the full year, the Company reported net income of $366,325, or $0.05 per diluted share, compared to a
    '/>"/>

  • SOURCE Misonix, Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8

    Related medicine technology :

    1. Misonix Announces New Distribution Agreement For Panama
    2. Misonix And SIAD Healthcare Renew Distribution Agreement For Italy
    3. Misonix Exhibits at Major Worldwide Spine Conference
    4. Misonix Adds Industry Veteran To Management Team
    5. Misonix Participates In Cleveland Spine Review
    6. Misonix And Soelim Create New Distribution Alliance For South Korea
    7. Misonix Inks New Distribution Agreement For Croatia And Slovenia
    8. Misonix Attends International Meeting On Advanced Spine Techniques (IMAST) - Introduces New Product
    9. Misonix Adds 6 Spine Sales Agencies In The U.S.
    10. Misonix Product Featured At Neurosurgery Congress
    11. Qmed, the Leading Global MedTech Industry Resource, Partners with Clarimed, to Provide the Medical Manufacturing and Healthcare Industry with FDA Reports on Adverse Events
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:11/18/2014)... , Nov. 18, 2014  NxStage ® ... leading manufacturer of innovative dialysis products , ... Express dialyzer for the in-center, hemodialysis market. ... which is designed to reduce the amount of ... the number of touch point contamination sites.  The ...
    (Date:11/18/2014)... N.J. , Nov. 18, 2014 ... 230,000 American women this year who get a ... today announced new resources for case managers to ... and 5—to navigate the myriad physical, emotional and ... resources are available at no cost via the ...
    (Date:11/18/2014)... , Nov. 18, 2014  TransCelerate BioPharma ... most recent manuscript on Risk-Based Monitoring (RBM), ... Quality Control Measure in Clinical Trials ," ... Innovation & Regulatory Science  (TIRS) journal. Developed ... with Medidata, the manuscript examines the value ...
    Breaking Medicine Technology:NxStage Launches New Streamline Express Dialyzer With Pre-attached Blood Tubing Set 2New Breast Cancer Resources: Commission For Case Manager Certification Adds Specialty Tools to Case Management Body of Knowledge Online Learning Center 2TransCelerate BioPharma Inc. Publishes Recommendation on Use of Source Data Verification in Risk-Based Monitoring, Releases Third Update on Initiative Progress 2TransCelerate BioPharma Inc. Publishes Recommendation on Use of Source Data Verification in Risk-Based Monitoring, Releases Third Update on Initiative Progress 3
    ... - Ambrilia,Biopharma Inc. (TSX:AMB), a biopharmaceutical company developing,novel ... and,cancer, held its Annual General and Special Meeting ... novel series of HIV,integrase inhibitors and recent developments ... Chairman of the Board, Mr. Frederic,Porte, and a ...
    ... 2007 /PRNewswire/ -- Results of the,Option (TOcilizumab ... first multinational Phase III study outside,of Japan, ... 4mg/kg,or 8mg/kg) plus methotrexate achieved a significant ... symptoms of moderate to,severe rheumatoid arthritis (RA) ...
    Cached Medicine Technology:Ambrilia Highlights Encouraging Data for its HIV Integrase,Inhibitor Program and Recent Developments at Annual Meeting 2Ambrilia Highlights Encouraging Data for its HIV Integrase,Inhibitor Program and Recent Developments at Annual Meeting 3Ambrilia Highlights Encouraging Data for its HIV Integrase,Inhibitor Program and Recent Developments at Annual Meeting 4Actemra (tocilizumab) Significantly Improves Symptoms of Rheumatoid,Arthritis Compared to a Current Standard of Care 2Actemra (tocilizumab) Significantly Improves Symptoms of Rheumatoid,Arthritis Compared to a Current Standard of Care 3Actemra (tocilizumab) Significantly Improves Symptoms of Rheumatoid,Arthritis Compared to a Current Standard of Care 4Actemra (tocilizumab) Significantly Improves Symptoms of Rheumatoid,Arthritis Compared to a Current Standard of Care 5
    (Date:11/21/2014)... (PRWEB) November 21, 2014 Porcelain ... picture-perfect smiles for patients in preparation for the coming ... the fronts of teeth, look completely natural, and can ... situations, veneers are also valued for their ability to ... and can be used on one or several teeth ...
    (Date:11/21/2014)... 20, 2014 (HealthDay News) -- Seeking to make it ... Food and Drug Administration on Thursday approved a new ... Hydrocodone -- best known by the brand name Vicodin ... tied to a surge in dangerous addictions across the ... Hysingla ER (hydrocodone bitartrate) is an extended-release tablet to ...
    (Date:11/21/2014)... 20, 2014 (HealthDay News) -- Certain genes might prevent ... to a fifth of people with type 2 diabetes, ... been pondered by doctors working with diabetic patients, one ... under the impression that exercise helps decrease insulin resistance ... Pena, director of the Center for Weight Management at ...
    (Date:11/21/2014)... 21, 2014 Richard Wolfe, co-founder ... will present advanced benefits administration strategies during the ... HR Leadership Summit. This Game Changer breakout session ... to present cutting-edge solutions and best practices to ... how real-time data exchange between health and welfare ...
    (Date:11/21/2014)... (PRWEB) November 21, 2014 Center for ... workshops titled “Massachusetts Insurance Funding for Autism Workshops” to ... navigate their way through the insurance coverage process. ... Massachusetts law and the most effective ways to access ... Dec. 4 from 6-8:00 p.m. at 331 Montvale Ave., ...
    Breaking Medicine News(10 mins):Health News:Los Angeles Porcelain Veneers Dentist, Dr. Kevin Sands, Now Creates Picture-Perfect Smiles for Patients for the Holiday Season 2Health News:FDA Approves 'Abuse-Resistant' Narcotic Painkiller 2Health News:FDA Approves 'Abuse-Resistant' Narcotic Painkiller 3Health News:Exercise Might Not Help Some Type 2 Diabetics Control Their Blood Sugar 2Health News:Exercise Might Not Help Some Type 2 Diabetics Control Their Blood Sugar 3Health News:Empyrean Benefit Solutions CEO Sharing Latest Benefits Administration Strategies with Houston HR Leaders 2Health News:Empyrean Benefit Solutions CEO Sharing Latest Benefits Administration Strategies with Houston HR Leaders 3Health News:Center for Autism and Related Disorders to Host Massachusetts Autism Insurance Workshops for Parents 2
    ... tests for liver fibrosis, such as liver stiffness measurement ... chronic hepatitis C, according to a new study in ... Gastroenterological Association (AGA) Institute. "Liver stiffness measurement ... evaluation of hepatitis C, regardless of the stage of ...
    ... 2020 strategy and its Innovation Union flagship initiative, the ... cooperation activities and how EUREKA could contribute to strengthening ... in the regions. High-level stakeholders and all interested ... conference,s discussions which will have a significant role in ...
    ... HealthDay Reporter , MONDAY, June 13 (HealthDay News) ... even though most people agree the government-sponsored health insurance program ... survive. Instead, respondents to a Harris ... should be shored up, in part, by lowering the fees ...
    ... sleep problems with cognitive-behavioral therapy for insomnia can reduce ... presented Tuesday, June 14, in Minneapolis, Minn., at SLEEP ... Sleep Societies LLC (APSS). Results show that about ... reported having suicidal thoughts or wishes during the past ...
    ... sleep per night is associated with higher ratings for quality ... abstract that will be presented Tuesday, June 14, in Minneapolis, ... Associated Professional Sleep Societies LLC (APSS). Results show that ... hours per night had higher self-reported scores for quality of ...
    ... By Randy Dotinga HealthDay Reporter , MONDAY, June ... help children solve problems more easily, a goal that can ... study suggests. The research doesn,t suggest that ordinary video ... how a particular type of training can boost brain skills ...
    Cached Medicine News:Health News:Noninvasive liver tests may predict hepatitis C patient survival 2Health News:Poll Finds Little Support for GOP Plan to Privatize Medicare 2Health News:Poll Finds Little Support for GOP Plan to Privatize Medicare 3Health News:Cognitive-behavioral therapy for insomnia can reduce suicidal ideation 2Health News:The good life: Good sleepers have better quality of life and less depression 2Health News:Training via Video Game Shown to Boost Kids' Brain Power 2Health News:Training via Video Game Shown to Boost Kids' Brain Power 3
    Bacterial/Viral Filters for Anesthesia and Respiratory Applications...
    Bacterial/Viral Filters for Anesthesia and Respiratory Applications...
    Ballard trach care HMES and filters, universal use, "Y" filter, CO 2 sampling port...
    Indications For Usage: ,Single patient use on anesthetized patients and respiratory care patients who require a breathing circuit. The product is intended to be replaced at least once every 24 hours...
    Medicine Products: